Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands

被引:21
作者
Banister, Samuel D. [1 ]
Moussa, Iman A. [1 ]
Beinat, Corinne [1 ]
Reynolds, Aaron J. [1 ]
Schiavini, Paolo [1 ]
Jorgensen, William T. [1 ]
Kassiou, Michael [1 ,2 ,3 ]
机构
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
关键词
Trishomocubanes; Monoamine transporters; Sigma receptors; CNS; Structure-activity relationships; MONOAMINE TRANSPORTERS; IN-VIVO; PHARMACOLOGICAL CHARACTERIZATION; HIGH-AFFINITY; COCAINE; ANALOGS; RADIOLIGAND; CHEMISTRY; PET;
D O I
10.1016/j.bmcl.2010.11.075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In our continued exploration of trishomocubane derivatives with central nervous system (CNS) activity, N-arylalkyl-8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes (10-13) displaying affinity for the sigma (sigma) receptor were also found, in several cases, to interact with the dopamine transporter (DAT). Compound 12 was identified as the first trishomocubane-derived high affinity DAT ligand (K-1 = 1.2 nM), with greater than 8300-fold selectivity over the monoamine transporters NET and SERT, and only low to moderate affinity for sigma(1) and sigma(2) receptors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:38 / 41
页数:4
相关论文
共 33 条
[1]   Molecular imaging with PET [J].
Ametamey, Simon M. ;
Honer, Michael ;
Schubiger, Pius August .
CHEMICAL REVIEWS, 2008, 108 (05) :1501-1516
[2]   Bicyclo[2.2-1]heptanes as novel triple re-uptake inhibitors for the treatment of depression [J].
Axford, L ;
Boot, JR ;
Hotten, TM ;
Keenan, M ;
Martin, FM ;
Milutinovic, S ;
Moore, NA ;
O'Neill, MF ;
Pullar, IA ;
Tupper, DF ;
Van Belle, KR ;
Vivien, V .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3277-3280
[3]   Fluorine-18 Chemistry for PET: A Concise Introduction [J].
Banister, Samuel ;
Roeda, Dirk ;
Dolle, Frederic ;
Kassiou, Michael .
CURRENT RADIOPHARMACEUTICALS, 2010, 3 (02) :68-80
[4]   Oxo-bridged isomers of aza-trishomocubane sigma (σ) receptor ligands: Synthesis, in vitro binding, and molecular modeling [J].
Banister, Samuel D. ;
Moussa, Iman A. ;
Jordan, Meredith J. T. ;
Coster, Mark J. ;
Kassiou, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :145-148
[5]   The dopamine transporter: role in neurotoxicity and human disease [J].
Bannon, MJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) :355-360
[6]   BLOCKADE OF THE NORADRENALINE CARRIER INCREASES EXTRACELLULAR DOPAMINE CONCENTRATIONS IN THE PREFRONTAL CORTEX - EVIDENCE THAT DOPAMINE IS TAKEN UP INVIVO BY NORADRENERGIC TERMINALS [J].
CARBONI, E ;
TANDA, GL ;
FRAU, R ;
DICHIARA, G .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) :1067-1070
[7]   COCAINE AND 3-BETA-(4'-SUBSTITUTED PHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ESTER AND AMIDE ANALOGS - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER [J].
CARROLL, FI ;
KOTIAN, P ;
DEHGHANI, A ;
GRAY, JL ;
KUZEMKO, MA ;
PARHAM, KA ;
ABRAHAM, P ;
LEWIN, AH ;
BOJA, JW ;
KUHAR, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :379-388
[8]   Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter [J].
Chalon, S ;
Hall, H ;
Saba, W ;
Garreau, L ;
Dollé, F ;
Halldin, C ;
Emond, P ;
Bottlaender, M ;
Deloye, JB ;
Helfenbein, J ;
Madelmont, JC ;
Bodard, S ;
Mincheva, Z ;
Besnard, JC ;
Guilloteau, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01) :147-152
[9]   Structure and function of the dopamine transporter [J].
Chen, NH ;
Reith, MEA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :329-339
[10]   Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET [J].
Dollé, F ;
Emond, P ;
Mavel, S ;
Demphel, S ;
Hinnen, F ;
Mincheva, Z ;
Saba, W ;
Valette, H ;
Chalon, S ;
Halldin, C ;
Helfenbein, J ;
Legaillard, J ;
Madelmont, JC ;
Deloye, JB ;
Bottlaender, M ;
Guilloteau, D .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) :1115-1125